Showing results (81-90 of 11,522) with videos related to

Sort By:
Pageof 1,153
British Journal of Clinical Pharmacology|November 25, 2018
Pharmacogenetics of artemether-lumefantrine influence on nevirapine disposition: Clinically significant drug-drug interaction?Sa'ad T Abdullahi, Adeniyi Olagunju, Julius O Soyinka, et al.
British Journal of Clinical Pharmacology|May 1, 1988
Effect of bile on cyclosporin absorption in liver transplant patientsM U Mehta, R Venkataramanan, G J Burckart, et al.
British Journal of Clinical Pharmacology|May 1, 1988
Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillationR V Lewis, D G McDevitt
British Journal of Clinical Pharmacology|May 1, 1988
Warfarin dosage requirements: prospective clinical trial of a method for prediction from the response to a single doseD M Jupe, G M Peterson, R L Coleman, et al.
British Journal of Clinical Pharmacology|November 14, 2018
Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in ScotlandTanja Mueller, Samantha Alvarez-Madrazo, Chris Robertson, et al.
British Journal of Clinical Pharmacology|November 14, 2018
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillationPatrick Blin, Caroline Dureau-Pournin, Yves Cottin, et al.
British Journal of Clinical Pharmacology|April 5, 2019
Translating the dose response into risk and benefitJohn B Warren
British Journal of Clinical Pharmacology|September 1, 1986
Valpromide inhibits human epoxide hydrolaseG M Pacifici, M Franchi, C Bencini, et al.
British Journal of Clinical Pharmacology|March 29, 2019
Intravenous antazoline, a first-generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio-venous conduction and high clinical effectiveness (AntaEP Study)Michal M Farkowski, Aleksander Maciag, Ilona Kowalik, et al.
British Journal of Clinical Pharmacology|April 2, 2019
Warfarin dose requirement in patients having severe thrombosis or thrombophiliaTuukka A Helin, Lotta Joutsi-Korhonen, Heidi Asmundela, et al.
Pageof 1,153